ArticleCureus2026
Operative Efficiency, Technical Workflow, and Perioperative Outcomes in Minimally Invasive Trans-Kambin Oblique Thoracic Interbody Fusion (MIS-OTIF): A Retrospective Clinical Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Thoracolumbar fusion surgery has historically been associated with prolonged operative duration, extensive posterior muscle dissection, elevated blood loss, prolonged hospitalization, and increased perioperative morbidity. Over the last decade, minimally invasive spinal surgery has evolved substantially with the goal of reducing tissue disruption while preserving biomechanical stabilization and neural decompression. Minimally invasive trans-Kambin oblique thoracic interbody fusion (MIS-OTIF) represents an extension of minimally invasive principles into the thoracic and thoracolumbar spine through an oblique trans-Kambin corridor that minimizes posterior soft tissue injury while facilitating efficient instrumentation and interbody reconstruction. Objective To evaluate operative efficiency, perioperative workflow characteristics, obesity-related technical considerations, and complication profiles in patients undergoing MIS-OTIF procedures. Methods A retrospective review of consecutive patients undergoing MIS-OTIF procedures between 2020 and 2026 was performed. Variables analyzed included operative time, body mass index (BMI), revision status, number of instrumented levels, hybrid versus pure minimally invasive technique, and complications. Results Twenty-five MIS-OTIF procedures were reviewed. Operative duration ranged from 30 to 171 minutes depending on procedural complexity, revision status, and the addition of posterior instrumentation or open components. Mean BMI across the cohort demonstrated that MIS-OTIF remained technically feasible even in obese and morbidly obese patients. Single-level thoracic MIS-OTIF procedures demonstrated the shortest operative duration, while hybrid constructs, multilevel fusion procedures, and revision surgeries required longer operative times. Elevated BMI alone did not significantly increase operative duration. Complication rates remained low, with isolated cases of persistent stenosis identified which were unrelated to surgical technique itself. Conclusion MIS-OTIF demonstrates favorable operative efficiency with acceptable operative duration across a broad range of thoracic and thoracolumbar pathologies, including obese and revision patients. The minimally invasive trans-Kambin oblique corridor may reduce operative exposure time, tissue disruption, blood loss, and physiologic stress while maintaining efficient workflow and stabilization. Larger multicenter prospective studies are warranted to further validate the reproducibility and long-term outcomes of MIS-OTIF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.